Epidemiol Rev. 2020 Jan 31;42(1):167-170. doi: 10.1093/epirev/mxaa004.
The National Institutes of Health is investing hundreds of millions of dollars into new research on opioids. As these studies yield insights and results, their results will have to change policy and practice before they can bend the curve of the epidemic. However, the United States does not have a strong track record of translating evidence on drug policy into action. Three reasons for the translation gap are the historical legacy of drugs in the United States, vested interests, and politics. Researchers can become engaged in policy and political processes to strengthen the US response.
美国国立卫生研究院正在投入数亿美元用于阿片类药物的新研究。随着这些研究产生新的见解和结果,它们必须改变政策和实践,才能扭转这一流行趋势。然而,美国在将毒品政策证据转化为行动方面没有良好的记录。造成这种转化差距的三个原因是美国毒品的历史遗留问题、既得利益和政治。研究人员可以参与政策和政治进程,以加强美国的应对措施。